From the Research
Reduction in Blood Glucose Levels
- The reduction in blood glucose levels caused by 1 unit of Actrapid (human insulin) is not directly stated in the provided studies.
- However, a study 1 compared the pharmacokinetic and pharmacodynamic properties of subcutaneous regular human insulin (Actrapid) and oral insulin in a capsule form (Capsulin) in persons with type 2 diabetes.
- The study found that administration of 12U sc Actrapid increased glucose infusion rates (GIRs) and reached a maximum value at approximately 280-330 min.
- The maximum GIR values were higher for Actrapid than for oral insulin (Capsulin) 1.
- Another study 2 compared the effectiveness of various routes of insulin injection and found that intramuscular insulin injection produced a maximal increase in plasma insulin at 50 minutes and caused a 35% drop in plasma glucose at 60 minutes.
- The study also found that subcutaneous injection of insulin produced a highest increase in plasma insulin at 180 minutes and caused a 23% drop in plasma glucose 2.
- However, the exact reduction in blood glucose levels caused by 1 unit of Actrapid (human insulin) cannot be determined from these studies.